Cargando…
Re-thinking preclinical models of cancer metastasis
Autores principales: | Ullo, Maria F., Logue, Jeremy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231447/ https://www.ncbi.nlm.nih.gov/pubmed/30460323 http://dx.doi.org/10.18632/oncoscience.450 |
Ejemplares similares
-
Re-thinking the inclusion of race in British hypertension guidance
por: Gopal, Dipesh P., et al.
Publicado: (2021) -
MEN1 Surveillance Guidelines: Time to (Re)Think?
por: Newey, Paul J, et al.
Publicado: (2022) -
ADF and cofilin-1 collaborate to promote cortical actin flow and the leader bleb-based migration of confined cells
por: Ullo, Maria F, et al.
Publicado: (2021) -
Evaluation of public involvement in research: time for a major re-think?
por: Edelman, Natalie, et al.
Publicado: (2015) -
Re-thinking the preclinical development of GBM therapeutics
por: Cosset, Érika, et al.
Publicado: (2018)